Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.

Human psychopharmacology - 1 Jan 2011

Souza Renan P, Meltzer Herbert Y, Lieberman Jeffrey A, Voineskos Aristotle N, Remington Gary, Kennedy James L

Abstract excerpt

Previous studies investigated whether prolactin (PRL) serum level was a biomarker of antipsychotic response, schizophrenia symptomatology, and tardive dyskinesia. Most of the findings support that antipsychotic drugs modulate PRL levels but PRL is not a steady indicator. Recent results suggest a genetic effect of PRL and PRL receptor (PRLR) polymorphisms in PRL levels indicating that independently of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clozapine

Share to Dyskinesia, Drug-Induced

Share to Prolactin

Share to Receptors, Prolactin

Share to Schizophrenia

Share to White People

Source

Identifiers

PMID: 21305610
DOI: 10.1002/hup.1161

Genes

PRL
PRLR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.PMID 21305610Read ↗

Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.Semantic proximity Read ↗

Functional -1149 g/t polymorphism of the prolactin gene in schizophrenia.Semantic proximity Read ↗

Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.Semantic proximity Read ↗

Epidemiology and risk factors for (tardive) dyskinesia.Semantic proximity Read ↗

Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.Semantic proximity Read ↗

Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia.Semantic proximity Read ↗

Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.Semantic proximity Read ↗

Association of prolactin receptor (PRLR) variants with prolactinomasSemantic proximity Read ↗

Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid.Semantic proximity Read ↗

Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.Semantic proximity Read ↗

Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia.Semantic proximity Read ↗

[Association of the Level of Serum Prolactin with Polymorphic Variants of the GRIN2A, GPM3, and GPM7 Genes in Patients with Schizophrenia Taking Conventional and Atypical Antipsychotics].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.